Severe motor and vocal tics controlled with Sativex®.

Objectives: A single case report on cannabinoid treatment for treatment-resistant Tourette syndrome (TS).

Method: Our subject received 10.8 mg Tetrahydocannabinol and 10 mg cannabidiol daily, in the form of two oro-mucosal sprays of 'Sativex', twice daily.

Drug injecting in patients in New Zealand Methadone Maintenance Treatment programs: an anonymous survey.

Introduction And Aims: To investigate the prevalence and nature of injecting behaviour among patients on Methadone Maintenance Treatment (MMT) programs.

Design And Methods: A self-reported questionnaire was handed to 423 patients enrolled in MMT across six clinics in the lower North Island of New Zealand.

Results: A total of 151 patients responded, giving a 35.